Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)

SHE:002317 Revenue

Guangdong Zhongsheng Pharmaceutical had revenue of 467.58M CNY in the quarter ending September 30, 2026, a decrease of -20.62%. This brings the company's total for the last twelve months to 2.10B, down -14.14% year-over-year. In the year 2025, Guangdong Zhongsheng Pharmaceutical had annual revenue of 2.52B with 2.24% growth. That makes Guangdong Zhongsheng Pharmaceutical the 14,168th largest company in the world by revenue and 2,526th in China.

• Revenue (ttm): 2.10B
• Revenue Growth: -14.14%
• P/S Ratio: 8.90
• Revenue / Employee: 1.20M
• Employees: 1,757
• Market Cap: 18.72B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical Manufacturing 2.40B 95.3%
• Medicine Trade 102.71M 4.1%
• Unallocated Other Operating Income 15.49M 0.6%

Fiscal year ended Dec 31, 2025 See the full SHE:002317 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.52B	55.32M	2.24%
Dec 31, 2024	2.47B	-143.13M	-5.48%
Dec 31, 2023	2.61B	-65.60M	-2.45%
Jan 1, 2023	2.68B	247.06M	10.17%
Jan 1, 2022	2.43B	533.27M	28.13%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error